ORGANIZATION

Generic Association Aims to Contribute to Pre-Symptomatic and Preventive Care: New Industry Vision

July 9, 2019

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Japan Generic Medicines Association (JGA) announced the outline of a next-generation vision for the industry that would include contributing to pre-symptomatic and preventive care at an annual meeting of the Japan Society of Generic and Biosimilar Medicines held in…

To read the full story

Generic Association to Present Policy Proposal for Govt’s 2020 Honebuto Policy
November 20, 2019
Generic Association Focuses on Pre-symptomatic/Preventive Care and Overseas Expansion in “Post-80% Era”
October 2, 2019

ORGANIZATION

EFPIA Japan, Patient Groups Call for Stronger Health Literacy, PPI
December 22, 2025
JPMA Exec Renews Call for Simpler Drug Pricing System
December 19, 2025
JGA to Create “Stable Supply Network” Membership to Expand Ramp-Up Scheme
December 18, 2025
Pharma Groups Reiterate “No” to Broader CEA Use, Huge-Seller and Spillover Rules: Joint Statement
December 17, 2025
Japan Medical Societies Recommend RSV Vaccination for Older Adults
December 15, 2025

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COMMENTARY

FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed

By Takashi Ebisawa

Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…